does glp-1 cause depression The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy GLP-1 Depression Risk: What Research

First-time prescribing rates of AOM semaglutide increased in early 2024 and then have remained relatively stable and flat

Dealing with the global menace of antibiotic resistance requires a One Health approach across human medicine, agriculture, and the environment

How We Evaluated This review was conducted using publicly available information and does not represent a clinical evaluation, endorsement, or recommendation

Sam Rhee bids farewell to 'Three Plastic Surgeons and a Fourth' and celebrates its five-year run

The measured semaglutide content substantially exceeded the labeled amount in each sample by 29% to 39%, meaning that users could receive up to 39% more semaglutide per injection